Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records
Jas Bindra,1 Ishveen Chopra,2 Kyle Hayes,3 John Niewoehner,3 Mary Prince Panaccio,3 George J Wan3 1Falcon Research Group, North Potomac, MD, USA; 2Manticore Consultancy, Bethesda, MD, USA; 3Mallinckrodt Pharmaceuticals, Bridgewater, NJ, USACorrespondence: George J Wan, Mallinckrodt Pharmaceuticals,...
Main Authors: | Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio MP, Wan GJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-02-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/acthar-gel-in-african-americans-versus-non-african-americans-with-symp-peer-reviewed-fulltext-article-TCRM |
Similar Items
-
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis
by: Bindra J, et al.
Published: (2023-10-01) -
Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
by: Ying Zhou, et al.
Published: (2016-01-01) -
A Narrative Review of Acthar Gel for the Treatment of Myositis
by: Tanya Chandra, et al.
Published: (2023-03-01) -
Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
by: James Tumlin, et al.
Published: (2017-09-01) -
Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
by: Bindra J, et al.
Published: (2021-05-01)